Health-care companies rose as traders rotated into defensive sectors because of recession fears.
Biogen shares fell after the biotech company reported a lower second-quarter profit and the termination of a joint drug-development program.
Eli Lilly shares rally after its obesity drug Zepbound, also known as Mounjaro, showed promise in a clinical trial on patients with a common form of heart failure.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
08-01-24 1709ET
